[go: up one dir, main page]

DK1613297T3 - Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin - Google Patents

Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin

Info

Publication number
DK1613297T3
DK1613297T3 DK03779987T DK03779987T DK1613297T3 DK 1613297 T3 DK1613297 T3 DK 1613297T3 DK 03779987 T DK03779987 T DK 03779987T DK 03779987 T DK03779987 T DK 03779987T DK 1613297 T3 DK1613297 T3 DK 1613297T3
Authority
DK
Denmark
Prior art keywords
therapeutic compound
capsaicin
matrix containing
containing capsaicin
therapeutic patch
Prior art date
Application number
DK03779987T
Other languages
Danish (da)
English (en)
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1613297T3 publication Critical patent/DK1613297T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03779987T 2003-04-14 2003-11-19 Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin DK1613297T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46263003P 2003-04-14 2003-04-14
PCT/EP2003/012929 WO2004089361A1 (fr) 2003-04-14 2003-11-19 Dispositif therapeutique transdermique dote d'une matrice de polysiloxane contenant de la capsaicine

Publications (1)

Publication Number Publication Date
DK1613297T3 true DK1613297T3 (da) 2007-09-24

Family

ID=33159857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03779987T DK1613297T3 (da) 2003-04-14 2003-11-19 Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin

Country Status (23)

Country Link
US (2) US8821920B2 (fr)
EP (1) EP1613297B1 (fr)
JP (1) JP4943657B2 (fr)
KR (1) KR101050672B1 (fr)
CN (2) CN100512806C (fr)
AT (1) ATE363900T1 (fr)
AU (1) AU2003289710B2 (fr)
BR (1) BRPI0318250B8 (fr)
CA (1) CA2517493C (fr)
CY (1) CY1106744T1 (fr)
DE (1) DE60314298T2 (fr)
DK (1) DK1613297T3 (fr)
ES (1) ES2288222T3 (fr)
IL (1) IL171249A (fr)
MX (1) MXPA05011012A (fr)
NO (1) NO337896B1 (fr)
NZ (1) NZ541956A (fr)
PL (1) PL219512B1 (fr)
PT (1) PT1613297E (fr)
RU (1) RU2349315C9 (fr)
UA (1) UA81665C2 (fr)
WO (1) WO2004089361A1 (fr)
ZA (1) ZA200506462B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA012599B1 (ru) 2003-04-10 2009-10-30 Ньюроджескс, Инк. Способы и композиции для введения агонистов trpv1
DE102004044578A1 (de) 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
BRPI0607461A2 (pt) * 2005-02-14 2009-09-08 Neurogesx Inc dispositivo para liberação de agonistas de trpv1
WO2006105481A1 (fr) * 2005-03-30 2006-10-05 Neurogesx, Inc. Timbre transdermique a faible concentration de capsaicine et procedes de traitement des douleurs neuropathiques
JP4505644B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シート
JP4505645B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シートの貼付方法
JP4505646B2 (ja) * 2006-02-20 2010-07-21 フジコピアン株式会社 固定シート
JP4505649B2 (ja) * 2006-03-23 2010-07-21 フジコピアン株式会社 固定シート
JP2007284370A (ja) * 2006-04-14 2007-11-01 Alcare Co Ltd 体表面用貼付材
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
EP2155175B1 (fr) * 2007-06-08 2014-03-12 Samyang Biopharmaceuticals Corporation Système d'administration de médicaments par voie transdermique du type matrice et son procédé de préparation
KR101857827B1 (ko) * 2010-06-09 2018-05-14 카오카부시키가이샤 수증기 발생 온열구
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
HK1220384A1 (zh) * 2013-03-14 2017-05-05 Allergan, Inc. 包含比马前列素的局部组合物和利用其刺激毛发生长的方法
DK2810646T3 (en) * 2013-06-04 2016-10-31 Lts Lohmann Therapie Systeme Ag A transdermal
US10046151B2 (en) 2013-07-03 2018-08-14 Lts Lohmann Therapie-Systeme, Ag Transdermal therapeutic system with electronic component
CN104586818A (zh) * 2013-11-01 2015-05-06 北京中卫神农慢性病医学研究院有限公司 辣椒碱微孔久释器材
KR101574760B1 (ko) * 2013-11-13 2015-12-04 주식회사 엘지생활건강 흡수속도를 개선한 마이크로니들 시스템
ES2924899T3 (es) 2014-05-20 2022-10-11 Lts Lohmann Therapie Systeme Ag Sistema de administración transdérmica que contiene rotigotina
CA2948221C (fr) 2014-05-20 2022-11-22 Lts Lohmann Therapie-Systeme Ag Systeme d'administration transdermique comprenant un mediateur d'interface
CN106456567A (zh) 2014-05-20 2017-02-22 Lts勒曼治疗系统股份公司 在经皮递送系统中调节活性剂释放的方法
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
CN104546805A (zh) * 2014-12-15 2015-04-29 刘闯 一种治疗皮肤色斑的药膏贴
EP3266472A1 (fr) * 2016-07-08 2018-01-10 Mölnlycke Health Care AB Pansement médical comprenant un support et un matériau composite
KR101880442B1 (ko) * 2017-02-02 2018-07-23 대구한의대학교산학협력단 혈압 강하용 패치 조성물
US12383509B2 (en) * 2017-09-04 2025-08-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an emulsifier
BR112022018608A2 (pt) 2020-03-17 2022-11-08 Gruenenthal Gmbh Aplicação tópica repetida de emplastro de capsaicina para o tratamento de não-respondedores iniciais
KR20220164022A (ko) 2020-04-03 2022-12-12 그뤼넨탈 게엠베하 캡사이신 패치의 반복된 국소 적용 요법
TWI807338B (zh) * 2020-06-26 2023-07-01 美商美國禮來大藥廠 結合ＴＧＦ-α及表皮調節素（ＥＰＩＲＥＧＵＬＩＮ）之抗體於治療疼痛之用途
US11234947B2 (en) * 2020-06-30 2022-02-01 Imperial College Innovations Limited Treatment of peripheral neuropathy induced by cancer chemotherapy
JP7683009B2 (ja) * 2020-12-30 2025-05-26 エルケム・シリコーンズ・シャンハイ・カンパニー・リミテッド カプサイシン含有シリコーンゲルでコーティングされたパッチ
CN120752028A (zh) * 2023-03-15 2025-10-03 Lts罗曼治疗系统股份公司 包含辣椒素的医用贴剂
WO2024189213A1 (fr) * 2023-03-15 2024-09-19 Lts Lohmann Therapie-Systeme Ag Patch médical comprenant un agent actif irritant la peau
WO2025087915A1 (fr) * 2023-10-23 2025-05-01 Lts Lohmann Therapie-Systeme Ag Timbre médical comprenant de la capsaïcine ou un analogue de capsaïcine

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946106A (en) 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4053580A (en) 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US5145682A (en) 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
GB8704755D0 (en) 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
CN1037242C (zh) * 1994-04-22 1998-02-04 天津轻工业学院 以干红辣椒为原料制备辣椒碱的方法
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
RU2097057C1 (ru) * 1995-11-15 1997-11-27 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав мази болеутоляющего и местнораздражающего действия с тепловым эффектом
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
CA2267049A1 (fr) * 1999-02-05 2000-08-05 Bioglan Laboratories Ltd. Compositions pharmaceutiques
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
BR0012152A (pt) * 1999-07-02 2002-03-12 Lohmann Therapie Syst Lts Sistema de microrreservatórios na base de polissiloxanos e solventes ambifìlicos
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10114382A1 (de) 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
JP3989188B2 (ja) * 2001-04-27 2007-10-10 クリストファー・エム・キム 蜂針を用いない蜂毒療法
CA2447302C (fr) * 2001-05-01 2008-07-29 A.V. Topchiev Institute Of Petrochemical Synthesis Composition bioadhesive biphase absorbant l'eau
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
WO2003015698A2 (fr) * 2001-08-13 2003-02-27 University Of Pittsburgh Application de vehicules lipidiques et utilisation dans le cadre de l'administration de medicaments
US7247315B2 (en) * 2001-08-17 2007-07-24 Lavipharm Laboratories Inc. Compositions and medical device for transdermal delivery of a drug and methods of making and using same
US8246979B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine

Also Published As

Publication number Publication date
CN1784222A (zh) 2006-06-07
PL378806A1 (pl) 2006-05-15
DE60314298T2 (de) 2008-01-31
BR0318250A (pt) 2006-05-23
MXPA05011012A (es) 2005-12-12
BRPI0318250B8 (pt) 2021-05-25
BRPI0318250B1 (pt) 2015-08-11
KR20060002997A (ko) 2006-01-09
WO2004089361A1 (fr) 2004-10-21
HK1136957A1 (en) 2010-07-16
ATE363900T1 (de) 2007-06-15
EP1613297A1 (fr) 2006-01-11
RU2349315C9 (ru) 2010-02-27
ES2288222T3 (es) 2008-01-01
PT1613297E (pt) 2007-08-23
DE60314298D1 (de) 2007-07-19
CY1106744T1 (el) 2012-05-23
CA2517493A1 (fr) 2004-10-21
RU2349315C2 (ru) 2009-03-20
JP4943657B2 (ja) 2012-05-30
NO337896B1 (no) 2016-07-04
RU2005134984A (ru) 2007-05-27
CN101601664A (zh) 2009-12-16
CN100512806C (zh) 2009-07-15
NZ541956A (en) 2008-09-26
AU2003289710B2 (en) 2009-07-30
HK1090844A1 (zh) 2007-01-05
CA2517493C (fr) 2011-05-31
ZA200506462B (en) 2006-05-31
UA81665C2 (ru) 2008-01-25
EP1613297B1 (fr) 2007-06-06
US20040202707A1 (en) 2004-10-14
US8821920B2 (en) 2014-09-02
KR101050672B1 (ko) 2011-07-19
CN101601664B (zh) 2012-05-23
IL171249A (en) 2010-06-16
AU2003289710A1 (en) 2004-11-01
PL219512B1 (pl) 2015-05-29
JP2006514977A (ja) 2006-05-18
NO20055310L (no) 2005-11-10
US20140335150A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
DK1613297T3 (da) Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin
PT1524975E (pt) Sistema aperfeicoado de administracao transdermica para a administracao de rotigotina
ATE432693T1 (de) Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
IL192100A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
TW200637529A (en) Topical patch cooling preparation and methods for using the same
WO2007095615A3 (fr) Utilisation de derives de benzo-heteroaryl sulfamide dans le traitement de la douleur
BR112015013660A2 (pt) sistema de entrega transdérmica
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
ATE422877T1 (de) Zusammensetzungen zur haarbehandlung
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
DE60309329D1 (de) Verbessertes transdermales abgabesystem
WO2004069286A3 (fr) Systeme therapeutique transdermique apte a une application thermique visant a augmenter la permeation de substances actives, et utilisation associee
HK1220125A1 (zh) 拉喹莫德的透皮配方
ATE468849T1 (de) Idebenon zur behandlung von muskeldystrophien
BRPI0520258A2 (pt) uso de uma composição farmacêutica, método para preparar uma composição farmacêutica, e, uso de uma quantidade eficaz de acetato de eslicarbazepina
JP2003212765A (ja) 水虫の活動を停止させる溶液
DE20221247U1 (de) Transdermal-Pflaster zum Verabreichen von Fentanyl
IL182297A (en) Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
CO6450633A2 (es) Parche terapeutico para puntos de trigger y acupuntura para la terapia meridiana
TH105390A (th) สิ่งเตรียมใช้ที่ผิวหนังภายนอกในรูปแบบของอีมัลชั่นน้ำในน้ำมันที่ประกอบด้วยเซราไมด์
JP2009106715A (ja) 磁石又はゲルマニウム入りシップ剤
ATE425765T1 (de) Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen
UA94079C2 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
TH152250A (fr)